Higher doses of theacrine (6-9 mg/kg) increased salivary cortisol compared to placebo, but did not enhance subjective energy, cognitive performance, or cardiovascular measures in healthy adults . The mechanism behind theacrine's stimulant properties remains unclear.
Theacrine is a naturally occurring alkaloid structurally similar to caffeine, promoted as a stimulant that may provide energy without typical caffeine side effects like elevated heart rate or blood pressure. Prior research used relatively low doses (around 200 mg) and suggested theacrine could boost alertness without hemodynamic stress. This study tested whether higher doses would produce stronger effects or reveal previously missed impacts on cardiovascular and stress markers.
Researchers enrolled 19 habitual caffeine consumers (5 men, 14 women) in a randomized, double-blind, crossover design. Participants received placebo, 3 mg/kg theacrine, 6 mg/kg theacrine, or 9 mg/kg theacrine on separate visits spaced 7 days apart. For an average adult, these doses equate to roughly 210-630 mg of theacrine, well above the 200 mg used in earlier work. Researchers measured heart rate, blood pressure, subjective energy ratings, cognitive performance (type not specified in abstract), and two stress biomarkers: salivary cortisol and alpha-amylase.
The results were unexpected. Higher theacrine doses significantly elevated salivary cortisol at 120 and 180 minutes post-consumption compared to placebo. Despite this cortisol increase, participants reported no meaningful improvement in subjective energy across any theacrine condition, including placebo. Heart rate, blood pressure, alpha-amylase, and cognitive performance showed no significant changes with any theacrine dose. This pattern contradicts the premise that higher doses would amplify theacrine's proposed stimulant effects. Instead, the data suggest theacrine may trigger a stress response (cortisol elevation) without delivering the energy or cognitive benefits users seek.
The cortisol finding is particularly notable because this appears to be the first theacrine study measuring this biomarker. Cortisol elevation typically signals physiological stress activation, yet participants did not report feeling more energized. One interpretation: theacrine may activate stress pathways independent of subjective perception or behavioral consequence. Alternatively, the cortisol rise could reflect a mild systemic stress response that the body compensates for without obvious downstream effects on mood or cognition at these doses.
If you are considering theacrine as a caffeine alternative or energy supplement, current evidence does not support a clear benefit over placebo for subjective energy or cognitive performance, even at doses several times higher than previously tested. The cortisol elevation warrants caution if you are sensitive to stress markers or managing conditions where sustained cortisol elevation is contraindicated (certain autoimmune or metabolic conditions).
The study also highlights a common pattern in supplement research: preliminary or lower-dose studies can suggest benefits that larger or higher-dose studies fail to replicate. If you rely on stimulants for sustained focus or energy, established alternatives like caffeine have far more extensive evidence on dosing, timing (caffeine-delay is worth considering), and individual variability. Non-pharmacological approaches such as morning-sunlight exposure, sleep-duration optimization, zone-2-cardio, and deep-work structure remain foundational and evidence-backed.
This is a single small study; the findings require replication before drawing final conclusions. If you are already using theacrine and feeling benefit, this study does not prove harm. However, it does suggest the mechanism is not yet understood and that subjective reports alone are an incomplete guide to its physiological effects.
| Attribute | Details |
|---|---|
| Study type | Randomized, double-blind, placebo-controlled crossover |
| Sample | 19 healthy adults (5M, 14F), habitual caffeine users |
| Interventions | Placebo, 3 mg/kg theacrine, 6 mg/kg theacrine, 9 mg/kg theacrine |
| Washout | 7 days between visits |
| Primary outcomes | Salivary cortisol, alpha-amylase, heart rate, blood pressure, subjective energy, cognitive performance |
| Key finding | Cortisol elevation at higher doses; no effect on energy, cognition, or cardiovascular measures |
| Evidence tier | B tier (RCT, small sample, single study) |
| Registry | NCT07376564 |
Assessing the impact of high theacrine doses on hemodynamic measures, cognitive performance, and physiological stress. *Applied Physiology, Nutrition, and Metabolism*. PubMed ID: 41950524
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.